Northwire Canada EditionSaturday, July 18, 2026
Northwire
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%
M&A / Property

Well Health, Healwell roll out Welltrust

AIDX · Price

Executive Summary

  • Well Health Technologies Corp. and Healwell AI Inc. have launched the first phase of "Welltrust," a secure, consent-driven platform designed to accelerate clinical research recruitment by identifying high-fit patients for trials within Well-operated clinics in Canada.
  • The platform leverages Healwell's proprietary Darwen AI to enable privacy-preserving, scalable patient identification and engagement for chronic or complex conditions, while maintaining strict Canadian privacy and regulatory compliance.
  • This initiative establishes a scalable, consent-driven data infrastructure for life sciences partners and lays the foundation for future applications, including real-world evidence generation and enhanced clinical decision support tools.

Key Details

  • Platform Launch: Introduction of "Welltrust," a joint initiative between Well Health Technologies Corp. and Healwell AI Inc.
  • Core Function: Enables secure, consent-driven patient identification for clinical research within Well-operated clinics across Canada.
  • AI Integration: Utilizes Healwell's "Darwen AI" platform to identify and engage high-fit patients with chronic or complex conditions who have explicitly consented to trial outreach.
  • Consent Framework: Patients can voluntarily consent to be contacted about clinical trials and information review studies; declining patients continue receiving standard care without impact.
  • Governance & Compliance: Features a unified privacy, consent, and data-governance layer designed to meet Canadian privacy and regulatory standards for partnerships with pharmaceutical sponsors and research organizations.
  • Future Expansion: Platform architecture supports additional use cases including real-world evidence generation and enhanced clinical decision support tools.
  • Network Scale: Leverages Well's ecosystem of 240+ owned and operated clinics in Canada (primary, specialized, and diagnostic care) and software solutions powering 43,000+ healthcare providers across the US and Canada.
  • Public Tickers: Well Health Technologies Corp. (TSX: WELL, OTC: WHTCF) | Healwell AI Inc. (TSX: AIDX, OTC: HWAIF)

Notable Quotes

  • Dr. Alexander Dobranowski, President of Healwell AI: "Welltrust embodies our commitment to responsible and impactful AI in health care. By integrating Healwell's data and AI capabilities directly into Well's clinical environment, we are creating an advanced AI-powered ethical patient identification and research acceleration platform. This will accelerate research and patient access to potentially life-saving innovations while respecting high standards of privacy and patient autonomy."
  • Dr. Michael Frankel, Chief Medical Officer of Well Health: "This launch marks a major step forward in our mission to empower patients and improve health care outcomes through the use of technology. Welltrust allows patients to participate in research to accelerate the next generation of therapeutics and diagnostics in a safe, transparent way. Welltrust enables partners in the life sciences ecosystem to work with a scalable, consent-driven data infrastructure."
Read the original news release →

More from Healwell AI Inc